Objective to study the binding function of recombinant human serum albumin (HSA) to small molecule drugs.
目的研究重组人血白蛋白与小分子药物的结合功能。
Biologics have a somewhat better success rate than small molecule drugs, but they remain far from a sure bet.
生物技术药物研发的成功率稍高于小分子药物,但它们距离稳赚不赔的目标仍相距甚远。
Conclusion The binding functions of recombinant and nature HSA to small molecule drugs were basically in agreement.
结论重组人血白蛋白与天然人血白蛋白小分子药物结合功能基本一致。
应用推荐